MHLW To Establish Research Team On Tamiflu-Resistant Flu Virus
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare decided to establish a emergency research team to inspect national Tamiflu (oseltamivir) resistant flu virus cases; Japan is the biggest consumer nation for Tamiflu. Japan's National Infectious Diseases Institute has seen recent reports from Miyagi and Shiga Prefectures where Tamiflu-resistant flu virus was found among children. In Europe and the U.S., such reports have been increasing recently. To prepare for a potential spread of such a virus, the MHLW team aims to establish treatment policy guidelines for the virus and gather information on group infection routes and Tamiflu administration. (Click here for more - Japanese language
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.